Raymond James Financial Inc Novo Cure LTD Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Novo Cure LTD stock. As of the latest transaction made, Raymond James Financial Inc holds 11,672 shares of NVCR stock, worth $267,638. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,672Holding current value
$267,638% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NVCR
# of Institutions
266Shares Held
76.7MCall Options Held
1.17MPut Options Held
318K-
Black Rock Inc. New York, NY12.1MShares$278 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$272 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA7.92MShares$182 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA4.31MShares$98.8 Million0.01% of portfolio
-
Nordwand Advisors, LLC Radnor, PA3.03MShares$69.5 Million12.67% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $2.41B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...